期刊文献+

前列地尔纳米结构脂质载体的制备及含量测定 被引量:1

The preparation and quality study of prostaglandin E1 nanostructure lipid carriers
下载PDF
导出
摘要 目的:制备前列地尔(PGE1)纳米结构脂质载体(NLC)并测定其含量。方法:以单硬脂酸甘油酯和miglyol812为脂质材料,采用超声分散法制得PGE1-NLC。采用C18柱(200mm×4.6mm,5μm),流动相为0.0067mol/L磷酸盐缓冲液(pH6.3)-乙腈(3:1,V/V),流速为1.2mL/min,柱后反应液为1mol/L氢氧化钾溶液,柱后反应管为聚四氟乙烯管(φ0.5mm×10m),检测波长为278nm,进样量为20μL,柱温为60℃。结果:制得PGE1-NLC粒径为54.89±10.02nm,平均Zeta电位为-14.5mV,包封率为98.2%,含量为98.5%。结论:制备的PGE1-NLC纳米结构脂质载体粒径小,药物包封率高,含量测定方法简单易行。 Objective:To prepare prostaglandin E1(PGE1) nanostructured lipid carriers(NLC),and determinate the content.Methods:The PGE1-NLC was prepared with GMS and Miglyol 812 as matrix material by ultrasonic technique.The separation was performed with a C18(200mm×4.6mm,5 μm)at 60℃,and the mobile phase was consisted of PBS(pH 6.3)-acetonitrile(3:1,V/V),the flow rate was 1.2 mL·min-1.PGE1-NLC was detected at 278 nm.Results:Mean diameter of the NLC was54.89±10.02nm and its zeta potential was-14.5 mV.Mean entrapment efficiency was 98.2%.Its content was 98.5%.Conclusion:PGE1-NLC with small particle sizes can improve drug loading capacity and the method is simple and feasible.
出处 《北方药学》 2011年第3期5-7,共3页 Journal of North Pharmacy
关键词 前列地尔 纳米结构脂质载体 含量测定 PGE1 Nanostructured lipid carriers Content determination
  • 相关文献

参考文献10

  • 1张扬,冉建民.前列地尔脂微球载体联合甲钴胺治疗糖尿病周围神经病变[J].广东医学,2007,28(7):1173-1174. 被引量:7
  • 2王丽.前列地尔的临床应用[J].天津药学,2006,18(2):52-54. 被引量:21
  • 3侯冬枝,谢长生,平其能.表面活性剂复配制备稳定的固体脂质纳米粒混悬液(英文)[J].中国药科大学学报,2005,36(5):417-422. 被引量:17
  • 4Zeta Potential theory.Malvern zetasizer nano se-ries user manual. .
  • 5Wissing SA,Kayser O,Muller RH.Solid lipid nanopartieles for parenteral drug delivery. Advanced Drug Delivery Reviews . 2004
  • 6Nasserik,Strijers RL,Dekhuijzen LSet al.Reproducibility of differ-ent methods for diagnosis and monitoring diabetic neuopathy (J). Electromyogr Clin Neuophysial . 1998
  • 7M Paul,N Razzouq,G Tixier,A Astier.Stability of prostaglandin E1 (PGE1) in aqueous solutions. Eur J Hospital Pharmacy Science . 2005
  • 8M. Radtke,R.H. Muller.Comparison of structural properties of solid lipid nanparticles (SLNTM) versus other lipid particles,. Proc. Int. SympControl. Rel. Bioact. Mater . 2000
  • 9Hsiu-O Ho Ming-Chun Hwang Shu-Ling Tseng Lun-Huei Lin Kuo-Tung Chen Han-Sun Chiang Brend W. Spur Patrick Y. -K. Wong and Ming-Thau Sheu.The percutaneous penetration of prostaglandin Eand its alkyl esters. Journal of Controlled Release . 1999
  • 10B Heurtault,P Saulnier,B Pech,JE Proust,JP Benoit.Physico-chemical stability of colloidal lipid particles. Biomaterials . 2003

二级参考文献36

共引文献42

同被引文献18

  • 1侯冬枝,谢长生,平其能.表面活性剂复配制备稳定的固体脂质纳米粒混悬液(英文)[J].中国药科大学学报,2005,36(5):417-422. 被引量:17
  • 2Muller RH,Lucks JS. Arzneistofftrager aus festen Lipidteilchen,Feste Lipidnanospharen(SLN)[P].European Patent.No.EP 0605497,1996.
  • 3Wissing SA,Kayser O,Muller RH. Solid lipid nanoparticles for parenteral drug delivery[J].Advanced Drug Delivery Reviews,2004,(09):1257-1272.
  • 4Muller RH,Radtke M,Wissimg SA. Nanostructurde lipid matrices for improved microencapsulation of drugs[J].International Journal of Pharmaceutics,2002,(12):121-128.
  • 5Hu FQ,Jiang SP,Du YZ. Praparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system[J].Colloids and Surfaces B:Biointerfaces,2005,(3-4):167-173.
  • 6Garcla-fuentes M,Aolors MJ,Torres D. Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures[J].Journal of Colloid and Interface Science,2005,(02):590-598.
  • 7Muller RH,Radtke M,Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs[J].International Journal of Pharmaceutics,2002,(1-2):121-128.
  • 8Mehnert W,Mader K. Solid lipid nanoparticles:production,characterizstion snd applicstions[J].Advanced Drug Delivery Reviews,2001,(2-3):165-196.
  • 9Teeranachaideekul V,Muller RH,Junyaprasert VB. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC) Effects offor-mulation parameters on physicochemical stability[J].International Journal of Pharmaceutics,2007,(1 -2):198-206.
  • 10Joshi M,Patravale V. Nanostructured lipid carrier (NLC) based gel of celecoxib[J].International Journal of Pharmaceutics,2008,(1 -2):124-132.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部